Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

Lancet Infect Dis. 2022 Sep;22(9):1279. doi: 10.1016/S1473-3099(22)00430-3. Epub 2022 Jul 14.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Drug Combinations
  • Humans
  • Immunocompromised Host
  • Lactams
  • Leucine
  • Nitriles
  • Proline
  • Ritonavir
  • SARS-CoV-2

Substances

  • Drug Combinations
  • Lactams
  • Nitriles
  • nirmatrelvir and ritonavir drug combination
  • Proline
  • Leucine
  • Ritonavir